Abstract
Hyponatremic and hepatic encephalopathy are common causes of metabolic encephalopathy that may coexist in patients with cirrhosis. The clinical picture is common to any metabolic encephalopathy and is characterized by a confusional syndrome that may evolve into coma. Chronic mild or minimal manifestations can be seen in both, but motor symptoms are more common in hepatic encephalopathy. Recent advances show that in addition to clinical manifestations both encephalopathies share some pathogenetic mechanisms. Dysfunction of astrocytes, osmotic changes in the brain and brain edema are present in both situations. Recognition of these abnormalities is important to plan therapy. New drugs that affect brain hydration may be useful for both encephalopathies.
Similar content being viewed by others
References
Adrogue HJ, Madias NE (2000) Hyponatremia. N Engl J Med 342:1581–1589
Amodio P, Del Piccolo F, Petteno E et al (2001) Prevalence and prognostic value of quantified electroencephalogram (EEG) alterations in cirrhotic patients. J Hepatol 35:37–45
Amodio P, Biancardi A, Montagnese S et al (2007) Neurological complications after orthotopic liver transplantation. Dig Liver Dis 39(8):740–747
Angeli P, Wong F, Watson H, Gines P (2006) Hyponatremia in cirrhosis: results of a patient population survey. Hepatology 44:1535–1542
Arieff AI (2001) Treatment of hyponatremic encephalopathy with antagonists to antidiuretic hormone. J Lab Clin Med 138:8–10
Arieff AI, Guisado R (1976) Effects on the central nervous system of hypernatremic and hyponatremic states. Kidney Int 10:104–116
Arieff AI, Llach F, Massry SG (1976) Neurological manifestations and morbidity of hyponatremia: correlation with brain water and electrolytes. Medicine (Baltimore) 55:121–129
Blei AT, Cordoba J (2001) Hepatic encephalopathy. Practice guidelines of the American College of Gastroenterology. Am J Gastroenterol 96:1968–1976
Brusilow SW (1986) Hepatic encephalopathy (letter). N Eng J Med 314:786
Bustamante J, Rimola A, Ventura P et al (1999) Prognostic significance of hepatic encephalopathy in patients with cirrhosis. J Hepatol 30:890–895
Butterworth RF (1996) The neurobiology of hepatic encephalopathy. Semin Liver Dis 16:235–244
Butterworth RF (2003) Pathogenesis of hepatic encephalopathy: new insights from neuroimaging and molecular studies. J Hepatol 39:278–285
Clemmesen JO, Larsen FS, Kondrup J, Ott P (1999) Cerebral herniation in patients with acute liver failure is correlated with arterial ammonia concentration. Hepatology 29(3):648–653
Cooper JL, Plum F (1987) Biochemistry and physiology of brain ammonia. Physiol Rev 67:440–519
Cordoba J, Minguez B (2008) Hepatic encephalopathy. Semin Liver Dis 28:70–80
Cordoba J, Gottstein J, Blei AT (1996) Glutamine, myo-inositol and other organic osmolytes after portacaval anastomosis in the rat. Implications for ammonia-induced brain edema. Hepatology 24:919–923
Cordoba J, Gottstein J, Blei AT (1998) Hyponatremia exacerbates ammonia-induced brain edema in rats after portacaval anastomosis. J Hepatol 29:589–594
Cordoba J, Alonso J, Rovira A et al (2001) The development of low-grade cerebral edema in cirrhosis is supported by the evolution of 1H-magnetic resonance abnormalities after liver transplantation. J Hepatol 35:598–604
Cordoba J, Sanpedro F, Alonso J, Rovira A (2002) 1H-magnetic resonance in the study of hepatic encephalopathy in humans. Metab Brain Dis 17:415–429
Cordoba J, Raguer N, Flavia M et al (2003) T2 hyperintesity along the cortico-spinal tract in cirrhosis relates to functional abnormalities. Hepatology 38:1026–1033
Cordoba J, Guevara M, Watson H, Le Guennec S, Gines P (2009) Improvement of hyponatremia in cirrhosis increases speed of complex information processing. Hepatology 50 S4 451A
Donovan JP, Shafer DF, Shaw BW Jr, Sorrell MF (1998) Cerebral oedema and increased intracranial pressure in chronic liver disease. Lancet 351:719–721
Ferenci P, Lockwood A, Mullen K, Tarter R, Weissenborn K, Blei AT (2002) Hepatic encephalopathy—definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998. Hepatology 35:716–721
Gage PW, Quastel DM (1965) Influence of sodium ions on transmitter release. Nature 206:1047–1048
Garcia-Martinez R, Rovira A, Alonso J et al (2010) A long-term study of changes in the volume of brain ventricles and white matter lesions following successful liver transplantation. Transplantation (28), in press
Guevara M, Baccaro ME, Torre A et al (2009) Hyponatremia is a risk factor of hepatic encephalopathy in patients with cirrhosis: a prospective study with time-dependent analysis. Am J Gastroenterol 104:1382–1389
Haussinger D, Schliess F (2008) Pathogenetic mechanisms of hepatic encephalopathy. Gut 57:1156–1165
Haussinger D, Kircheis G, Fischer R, Schliess F, vom Dahl S (2000) Hepatic encephalopathy in chronic liver disease: a clinical manifestation of astrocyte swelling and low-grade cerebral edema? J Hepatol 32:1035–1038
Inouye SK (2006) Delirium in older persons. N Engl J Med 354:1157–1165
Jalan R, Kapoor D (2004) Reversal of diuretic-induced hepatic encephalopathy with infusion of albumin but not colloid. Clin Sci (Lond) 106:467–474
Jalan R, Dabos K, Redhead DN, Lee A, Hayes PC (1997) Elevation of intracranial pressure following transjugular intrahepatic portosystemic stent-shunt for variceal haemorrhage. J Hepatol 27:928–933
Kale RA, Gupta RK, Saraswat VA et al (2006) Demonstration of interstitial cerebral edema with diffusion tensor MR imaging in type C hepatic encephalopathy. Hepatology 43:698–706
Kreis R, Ross BD, Farrow NA, Ackerman Z (1992) Metabolic disorders of the brain in chronic hepatic encephalopathy detected with H-1 MR spectroscopy. Radiology 182:19–27
Lien YH, Shapiro JI, Chan L (1991) Study of brain electrolytes and organic osmolytes during correction of chronic hyponatremia. Implications for the pathogenesis of central pontine myelinolysis. J Clin Invest 88:303–309
Llach J, Gines P, Arroyo V et al (1988) Prognostic value of arterial pressure, endogenous vasoactive systems, and renal function in cirrhotic patients admitted to the hospital for the treatment of ascites. Gastroenterology 94:482–487
Manley GT, Fujimura M, Ma T et al (2000) Aquaporin-4 deletion in mice reduces brain edema after acute water intoxication and ischemic stroke. Nat Med 6:159–163
McManus ML, Churchwell KB, Strange K (1995) Regulation of cell volume in health and disease. N Engl J Med 333:1260–1266
Melton JE, Patlak CS, Pettigrew KD, Cserr HF (1987) Volume regulatory loss of Na, Cl, and K from rat brain during acute hyponatremia. Am J Physiol 252:F661–F669
Minguez B, Rovira A, Alonso J, Cordoba J (2007) Decrease in the volume of white matter lesions with improvement of hepatic encephalopathy. AJNR Am J Neuroradiol 28:1499–1500
Murphy N, Auzinger G, Bernel W, Wendon J (2004) The effect of hypertonic sodium chloride on intracranial pressure in patients with acute liver failure. Hepatology 39:464–470
Norenberg MD (1996) Astrocytic-ammonia interactions in hepatic encephalopathy. Semin Liver Dis 16:245–253
Ortiz M, Jacas C, Cordoba J (2005) Minimal hepatic encephalopathy: diagnosis, clinical significance and recommendations. J Hepatol 42(Suppl):S45–S53
Plum F, Posner JB (1982) The diagnosis of stupor and coma. Davis, Philadelphia
Poordad FF (2007) Review article: the burden of hepatic encephalopathy. Aliment Pharmacol Ther 25(Suppl 1):3–9
Rama Rao KV, Norenberg MD (2007) Aquaporin-4 in hepatic encephalopathy. Metab Brain Dis 22(3–4):265–275
Renneboog B, Musch W, Vandemergel X, Manto MU, Decaux G (2006) Mild chronic hyponatremia is associated with falls, unsteadiness, and attention deficits. Am J Med 119:71–78
Restuccia T, Gomez-Anson B, Guevara M et al (2004) Effects of dilutional hyponatremia on brain organic osmolytes and water content in patients with cirrhosis. Hepatology 39:1613–1622
Rovira A, Cordoba J, Raguer N, Alonso J (2002) Magnetic resonance imaging measurement of brain edema in patients with liver disease: resolution after transplantation. Curr Opin Neurol 15:731–737
Schrier RW, Gross P, Gheorghiade M et al (2006) Tolvaptan, a selective oral vasopressin V2-receptor antagonist, for hyponatremia. N Engl J Med 355:2099–2112
Shah NJ, Neeb H, Kircheis G, Engels P, Haussinger D, Zilles K (2008) Quantitative cerebral water content mapping in hepatic encephalopathy. Neuroimage 41:706–717
Sharma BC, Sharma P, Agrawal A, Sarin SK (2009a) Secondary prophylaxis of hepatic encephalopathy: an open-label randomized controlled trial of lactulose versus placebo. Gastroenterology 137:885–891, 891
Sharma P, Sharma BC, Sarin SK (2009b) Predictors of nonresponse to lactulose for minimal hepatic encephalopathy in patients with cirrhosis. Liver Int 29:1365–1371
Shawcross DL, Balata S, Olde Damink SWM et al (2004) Low myo-inositol and high glutamine levels in brain are associated with neuropsychological deterioration after induced hyperammonemia. Am J Physiol 287:G503–G509
Sterns RH, Cappuccio JD, Silver SM, Cohen EP (1994) Neurologic sequelae after treatment of severe hyponatremia: a multicenter perspective. J Am Soc Nephrol 4:1522–1530
Takahashi H, Koehler RC, Brusilow SW, Traytsman RJ (1992) Inhibition of brain glutamine accumulation prevents cerebral edema in hyperamonemic rats. Am J Physiol 261:H825–H829
Ware AJ, D’Agostino AN, Combes B (1971) Cerebral edema: a major complication of massive hepatic necrosis. Gastroenterology 61:877–884
Wasterlain CG, Torack RM (1968) Cerebral edema in water intoxication. II. An ultrastructural study. Arch Neurol 19:79–87
Acknowledgement
CIBERehd is supported by Instituto de Salud Carlos III.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Córdoba, J., García-Martinez, R. & Simón-Talero, M. Hyponatremic and hepatic encephalopathies: similarities, differences and coexistence. Metab Brain Dis 25, 73–80 (2010). https://doi.org/10.1007/s11011-010-9172-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11011-010-9172-3